EODData

OTCBB, NURPF: Neuren Pharmaceuticals Ltd

10 Nov 2025
LAST:

12.25

CHANGE:
 0.66
OPEN:
12.25
HIGH:
12.25
ASK:
0.00
VOLUME:
200
CHG(%):
5.11
PREV:
12.91
LOW:
12.25
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
10 Nov 2512.2512.2512.2512.25200
07 Nov 2512.9112.9112.9112.91100
04 Nov 2511.7311.7311.7311.734.2K

PROFILE

Name:Neuren Pharmaceuticals Ltd
About:Neuren Pharmaceuticals Limited, a biopharmaceutical company, develops drugs for the treatment of neurological disorders. It develops and commercializes DAYBUE (trofinetide) for the treatment of Rett syndrome in adults and pediatric patients 2 years of age and older, as well as in Phase 2 clinical trial to treat Fragile X syndrome. The company also develops NNZ-2591, which has completed Phase 2 clinical trial for the treatment of Phelan-McDermid; and in Phase 2 clinical trial for the treatment of Angelman and Pitt Hopkins. In addition, it develops NNZ-2591, which is in Preclinical trial stage for the treatment of Prader-Willi syndrome. The company was incorporated in 2001 and is based in Camberwell, Australia.
Sector:Healthcare
Industry:Biotechnology
Address:697 Burke Road, Camberwell, VIC, Australia, 3124
Website:https://www.neurenpharma.com
FIGI:BBG000QP8PX5

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:19.73 
Forward P/E:53.19 
Price to Sales:8.54 
Price to Book:8.74 
Revenue:218.86M 
EBITDA:184.1M 
Shares:126.29M 
Market Cap:1.547B 

TECHNICAL INDICATORS

MA5:12.411.3%
MA10:12.592.8%
MA20:12.643.2%
MA50:10.2519.5%
STO9:16.96 
STO14:34.14
RSI14:44.56
WPR14:-65.86
MTM14:-0.75
ROC14:-0.06 
ATR:1.24 
Week High:12.915.4%
Week Low:11.734.4%
Month High:13.359.0%
Month Low:11.73